Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Headspace Oxygen Level Control – V 2.0

Posted on By

Elixir Department: SOP for Headspace Oxygen Level Control – V 2.0

Standard Operating Procedure for Headspace Oxygen Level Control in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/108/2025
Supersedes SOP/ELX/108/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for controlling and monitoring the oxygen level in the headspace of mixing and storage tanks used in elixir manufacturing, in order to prevent oxidative degradation of sensitive ingredients.

2. Scope

This SOP applies to all tanks used for processing, holding, or transferring oxygen-sensitive elixirs in the Elixir Department, including nitrogen purging or inert gas blanketing systems.

3. Responsibilities

  • Production Operator:
    • Perform and document headspace oxygen level control activities.
  • Production Supervisor:
    • Review oxygen readings and ensure corrective actions where required.
  • QA Officer:
    • Verify compliance with specified oxygen limits and sign off before batch release.
See also  Elixir Department: SOP for Sampling of Final Product for QC - V 2.0

4. Accountability

The Head of Production is accountable for ensuring proper control of oxygen in the tank headspace and documentation of monitoring activities.

5. Procedure

5.1 Applicable Batches

  1. Refer to the Master Formula Record (MFR)
to identify if the product requires oxygen control.
  • Note the acceptable headspace oxygen level defined (typically below 2.0%).
  • 5.2 Equipment Preparation

    1. Ensure oxygen analyzer is calibrated and labeled “CALIBRATED.”
    2. Use only cleaned and validated sampling ports for measurement.
    3. Connect nitrogen (or other inert gas) to the tank inlet port using sterile filters (0.2 µm).

    5.3 Oxygen Level Monitoring Procedure

    1. Take initial oxygen reading in the headspace before purging using a handheld or inline oxygen analyzer.
    2. If oxygen level is above the permissible limit, initiate nitrogen purging.
    3. Open the vent slightly to allow displacement of oxygen with nitrogen.
    4. Continue purging until oxygen level is below the target (e.g., 2.0%).
    5. Record final oxygen level and time taken in the Oxygen Monitoring Log (Annexure-1).

    5.4 Post-Purging Controls

    1. Close inlet and outlet valves tightly to maintain inert environment.
    2. Affix label “OXYGEN CONTROLLED” on the tank and mention date/time.
    3. Repeat oxygen level check after 2 hours to ensure stability (if batch is held longer).

    5.5 Corrective Action

    1. If oxygen level exceeds the limit after storage, repeat nitrogen purging.
    2. Investigate for leaks or faulty gaskets and document deviation if applicable.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • MFR: Master Formula Record

    7. Documents

    1. Oxygen Monitoring Log (Annexure-1)
    2. Batch Manufacturing Record (BMR)
    3. Calibration Logbook for Oxygen Analyzer

    8. References

    • WHO TRS 1010 – GMP Guidelines
    • ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
    • 21 CFR Part 211.113 – Control of Microbial Contamination

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Oxygen Monitoring Log

    Date Batch No. Tank No. Initial O2 Level (%) Final O2 Level (%) Purge Duration (min) Operator QA Verified
    11/04/2025 ELX-1045 TANK-04 5.6% 1.8% 12 Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Updated oxygen control steps and log format Stability Enhancement QA Head
    See also  Elixir Department: SOP for Homogeneity Sampling - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: Antimicrobial Effectiveness Method Development – V 2.0
    Next Post: Gel Manufacturing: SOP for Validating Cleaning Procedures for Gel Equipment – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version